-
-
-
Sequence
- IKLSKⓍTKKⓍLKKVLKGⓍIKGⓍIAVAKMV
-
-
Original Sequence
- IKLSPETKDNLKKVLKGAIKGAIAVAKMV
-
Source
- Synthetic construct
-
-
Biological Activity
- Antimicrobial, Anticancer
-
- Function: Anticancer activity.
Ref.30789695 does not include results of antimicrobial, hemolysis and other biological assays
-
Target Organism
-
- [Ref.30789695] Cancer cell lines: A549 (IC50 = 3.26 ± 0.36 μM), HCT116 (IC50 = 3.05 ± 0.21 μM), HepG2 (IC50 = 1.50 ± 0.28 μM)
-
Hemolytic Activity
-
- No hemolytic activity information found.
-
Cytotoxicity
-
No cytotoxicity information found in the reference(s) presented
-
Linear/Cyclic
- Cyclic (Stapled)
-
N-terminal Modification
- Free
-
C-terminal Modification
- Amidation
-
Special Amino Acid and Stapling Position
- ① The Ⓧ (position: 6, 10, 18 and 22) in sequence indicate (S)-N-Fmoc-2-(4'-pentenyl)alanine. ② Ⓧ (6) and Ⓧ (10), Ⓧ (18) and Ⓧ (22) are cross-linked by ring-closing metathesis through an oct-4-enyl hydrocarbon staple, respectively.
-
-
Secondary Structure
- α-helical (most likely)
-
Structure Description
- No detailed structure description found.
-
-
There is no predicted structure for DRAMP29025.
- Literature 1
-
Title
- Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B: A Novel Glycosylated Staple Strategy
-
-
Reference
- ACS Chem Biol. 2019 Mar 15;14(3):516-525. doi: 10.1021/acschembio.9b00046. Epub 2019 Mar 1.
-
Author
- Yulei Li, Yihan Zhang, Minghao Wu, Qi Chang, Honggang Hu, Xia Zhao